---
title: Crystec Limited (CrystecPharma) vs Curia
slug_a: crystecpharma
slug_b: curiaglobal
site: cdmo
review_signal_gate: closed
canonical_path: /compare/crystecpharma/curiaglobal
---

# Crystec Limited (CrystecPharma) vs Curia

Side-by-side profile data from each company listing on this directory.

## Crystec Limited (CrystecPharma)

- Profile: [/companies/crystecpharma](/companies/crystecpharma)

Crystec Limited (CrystecPharma) — Crystec Limited (CrystecPharma) is a pharmaceutical technology company that offers its mSAS® supercritical-fluid particle engineering platform to improve the bioavailability, stability and delivery of small and large molecule therapeutics. Its work is aimed at clients developing new and existing medicines.

Services: 4. Modalities: 5. Indications: 1. Locations: 4. Certifications: 0. The strongest documented coverage currently appears in modalities (5).

### Services

- Solid-State Chemistry & Polymorph Screening
- Inhalation & Nasal Dosage Manufacturing
- Process Development
- Formulation Development

### Modalities

- Small Molecule
- Biologics (Monoclonal Antibodies)
- Biologics (Other)
- Oligonucleotide
- Peptide

### Development capabilities

- Formulation development

### Manufacturing capabilities

- Data not yet provided.

## Curia

- Profile: [/companies/curiaglobal](/companies/curiaglobal)

Curia — Global CDMO with 30+ years of experience offering integrated services across small molecule, generic APIs, sterile drug product, and biologics manufacturing, backed by 20+ facilities and 3,000+ professionals across North America, Europe, and India.

Services: 24. Modalities: 5. Indications: 0. Locations: 56. Certifications: 1. The strongest documented coverage currently appears in locations (56).

### Services

- Small Molecule Development & Manufacturing
- API Synthesis & Manufacturing
- HPAPI Manufacturing (High-Potency)
- Controlled Substance Manufacturing
- Flow Chemistry & Continuous Manufacturing
- Solid-State Chemistry & Polymorph Screening
- Biologics Development & Manufacturing
- Monoclonal Antibody (mAb) Manufacturing
- Recombinant Protein Manufacturing
- Cell-Line Development
- Upstream Processing
- Downstream Processing
- Microbial Fermentation
- mRNA Manufacturing
- Lipid Nanoparticle (LNP) Formulation
- Sterile Fill-Finish & Aseptic Manufacturing
- Lyophilization (Freeze Drying)
- Process Development
- Formulation Development
- Technology Transfer
- CMC Analytical Development
- Quality Control Testing
- Stability Testing & Storage
- CMC Regulatory Submission Support

### Modalities

- Small Molecule
- Biologics (Monoclonal Antibodies)
- Biologics (Other)
- mRNA
- Peptide

### Development capabilities

- Analytical method development
- Formulation development
- ICH stability testing
- Solid-state characterization
- Cell line development

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)
- Liquid Vials
- Lyophilized Vials
- Prefilled Syringes (PFS)
- Expression: Mammalian
- Expression: Microbial
- Expression: Viral Vector
- Single-Use / Disposable
- HPAPI
- DEA licensed
- Flow Chemistry